Tag: medical device clinical trials market size

Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

Medical Device Clinical Trials Market CAGR Outlook And Future Development

The medical device clinical trials market has experienced significant expansion in recent years. This market is projected to rise from $18.07 billion in 2025 to $19.36 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.2%. Historically, this growth can be ascribed to several factors, including an increase in medical device innovation, strict regulatory approval mandates, a heightened demand for patient safety validation, the enlargement of hospital-based clinical research, and greater investment in generating clinical evidence.

The medical device clinical trials market size is projected to experience substantial expansion over the upcoming years. It is forecast to reach $25.35 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 7.0%. Factors contributing to this anticipated growth during the forecast period include the rise of wearable and connected medical technologies, heightened regulatory oversight concerning device effectiveness, the proliferation of digital platforms for trials, a greater embrace of remote patient monitoring within studies, and the growing internationalization of clinical research. Key trends anticipated during the same period encompass the growing implementation of decentralized clinical trials, the expanding application of real-world evidence in device studies, an intensified emphasis on post-market approval and prolonged safety evaluations, the broadening of adaptive and hybrid trial methodologies, and a heightened need for trial management that adheres strictly to regulatory standards.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=61859328&type=smp&name=Medical%20Device%20Clinical%20Trials%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Medical Device Clinical Trials Market Demand Drivers Opening New Revenue Streams

The increasing occurrence of chronic diseases is projected to drive the growth of the medical device clinical trials market moving forward. These are long-term health conditions that advance slowly and necessitate continuous medical management. The proliferation of chronic diseases stems from sedentary lifestyles, where individuals spend extended hours seated at desks or engaged with electronic devices. This behavior reduces calorie expenditure and weakens cardiovascular health, contributing to conditions such as obesity, diabetes, and hypertension. The escalating incidence of chronic diseases, in turn, boosts the requirement for medical device clinical trials to create and validate innovative devices for effective diagnosis, treatment, and management. For instance, in June 2023, the Institute for Health Metrics and Evaluation, a US-based public health research institute, reported that over half a billion people globally were living with diabetes. This number is expected to more than double, reaching 1.3 billion people by 2050. Therefore, the rising prevalence of chronic diseases is accelerating the growth of the medical device clinical trials market.

Medical Device Clinical Trials Market Segment Landscape And Growth Outlook

The medical device clinical trials market covered in this report is segmented –

1) By Study Type: Feasibility And Pilot Study, Pivotal Study, FDA Premarket Approval (PMA) Application, Post-Approval Study

2) By Indication: Cardiovascular Devices, Neurology Devices, Orthopedic Devices, Diagnostic Imaging, Anesthesia And Respiratory Devices, Other Indications

3) By Study Design: Interventional, Observational, Expanded Access

Subsegments:

1) By Feasibility And Pilot Study: First-in-Human (FIH) Trials, Device Safety Assessment, Procedural Feasibility Studies, Prototype Testing

2) By Pivotal Study: Comparative Effectiveness Studies, Randomized Controlled Trials (RCTs), Non-Inferiority Trials, Superiority Trials

3) By FDA PMA (Pre-Market Approval) Application: Clinical Data Submission, Device Risk Analysis, Effectiveness Evidence Studies

4) By Post-Approval Study: Long-Term Safety Monitoring, Real-World Evidence Collection, Registry Studies, Comparative Outcome Studies

Medical Device Clinical Trials Market Trends Powering Strategic Industry Growth

Major companies active in the medical device clinical trials market are concentrating on developing AI-powered medical device software to streamline clinical trial protocols and resource allocation, aiming to boost trial efficiency and reduce expenditures. AI-powered medical device software refers to healthcare software that employs artificial intelligence algorithms, particularly machine learning or deep learning, to support or automate medical functions. For instance, in January 2025, Risklick, a pharmaceutical firm based in Switzerland, launched Protocol AI, an AI-driven software designed to accelerate and optimize clinical trials for medical devices. Protocol AI utilizes Natural Language Processing (NLP) and Machine Learning (ML) to analyze clinical data, publications, and regulatory documents, thereby automatically drafting clinical trial protocols within minutes. This innovation significantly decreases the time and cost associated with protocol development, which traditionally takes approximately six months, and has already shown up to a 50% reduction in document development time for medicinal products.

Medical Device Clinical Trials Market Competitive Landscape: Who Leads The Industry?

Major companies operating in the medical device clinical trials market are Abbott Laboratories, Siemens Healthineers, Stryker Corporation, Philips Healthcare, Baxter International, Roche Diagnostics, ICON, Intuitive Surgical, Edwards Lifesciences, Fortrea, Medidata, NAMSA, Veranex, TFS HealthScience, Avania, Parexel, Meditrial, Syneos Health, Qserve CRO, Clinius Ltd, Eclevar Medtech, 1med Sa, ISS AG

View The Full Medical Device Clinical Trials Market Report:

https://thebusinessresearchcompany.com/report/medical-device-clinical-trials-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Medical Device Clinical Trials Market Geographic Analysis: Where Is Demand Rising Fastest?

North America was the largest region in the medical device clinical trials market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical device clinical trials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

Medical Device Clinical Trials Market CAGR Outlook And Future Development

The medical device clinical trials market has experienced significant expansion in recent years. This market is projected to rise from $18.07 billion in 2025 to $19.36 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.2%. Historically, this growth can be ascribed to several factors, including an increase in medical device innovation, strict regulatory approval mandates, a heightened demand for patient safety validation, the enlargement of hospital-based clinical research, and greater investment in generating clinical evidence.

The medical device clinical trials market size is projected to experience substantial expansion over the upcoming years. It is forecast to reach $25.35 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 7.0%. Factors contributing to this anticipated growth during the forecast period include the rise of wearable and connected medical technologies, heightened regulatory oversight concerning device effectiveness, the proliferation of digital platforms for trials, a greater embrace of remote patient monitoring within studies, and the growing internationalization of clinical research. Key trends anticipated during the same period encompass the growing implementation of decentralized clinical trials, the expanding application of real-world evidence in device studies, an intensified emphasis on post-market approval and prolonged safety evaluations, the broadening of adaptive and hybrid trial methodologies, and a heightened need for trial management that adheres strictly to regulatory standards.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=61859328&type=smp&name=Medical%20Device%20Clinical%20Trials%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Medical Device Clinical Trials Market Demand Drivers Opening New Revenue Streams

The increasing occurrence of chronic diseases is projected to drive the growth of the medical device clinical trials market moving forward. These are long-term health conditions that advance slowly and necessitate continuous medical management. The proliferation of chronic diseases stems from sedentary lifestyles, where individuals spend extended hours seated at desks or engaged with electronic devices. This behavior reduces calorie expenditure and weakens cardiovascular health, contributing to conditions such as obesity, diabetes, and hypertension. The escalating incidence of chronic diseases, in turn, boosts the requirement for medical device clinical trials to create and validate innovative devices for effective diagnosis, treatment, and management. For instance, in June 2023, the Institute for Health Metrics and Evaluation, a US-based public health research institute, reported that over half a billion people globally were living with diabetes. This number is expected to more than double, reaching 1.3 billion people by 2050. Therefore, the rising prevalence of chronic diseases is accelerating the growth of the medical device clinical trials market.

Medical Device Clinical Trials Market Segment Landscape And Growth Outlook

The medical device clinical trials market covered in this report is segmented –

1) By Study Type: Feasibility And Pilot Study, Pivotal Study, FDA Premarket Approval (PMA) Application, Post-Approval Study

2) By Indication: Cardiovascular Devices, Neurology Devices, Orthopedic Devices, Diagnostic Imaging, Anesthesia And Respiratory Devices, Other Indications

3) By Study Design: Interventional, Observational, Expanded Access

Subsegments:

1) By Feasibility And Pilot Study: First-in-Human (FIH) Trials, Device Safety Assessment, Procedural Feasibility Studies, Prototype Testing

2) By Pivotal Study: Comparative Effectiveness Studies, Randomized Controlled Trials (RCTs), Non-Inferiority Trials, Superiority Trials

3) By FDA PMA (Pre-Market Approval) Application: Clinical Data Submission, Device Risk Analysis, Effectiveness Evidence Studies

4) By Post-Approval Study: Long-Term Safety Monitoring, Real-World Evidence Collection, Registry Studies, Comparative Outcome Studies

Medical Device Clinical Trials Market Trends Powering Strategic Industry Growth

Major companies active in the medical device clinical trials market are concentrating on developing AI-powered medical device software to streamline clinical trial protocols and resource allocation, aiming to boost trial efficiency and reduce expenditures. AI-powered medical device software refers to healthcare software that employs artificial intelligence algorithms, particularly machine learning or deep learning, to support or automate medical functions. For instance, in January 2025, Risklick, a pharmaceutical firm based in Switzerland, launched Protocol AI, an AI-driven software designed to accelerate and optimize clinical trials for medical devices. Protocol AI utilizes Natural Language Processing (NLP) and Machine Learning (ML) to analyze clinical data, publications, and regulatory documents, thereby automatically drafting clinical trial protocols within minutes. This innovation significantly decreases the time and cost associated with protocol development, which traditionally takes approximately six months, and has already shown up to a 50% reduction in document development time for medicinal products.

Medical Device Clinical Trials Market Competitive Landscape: Who Leads The Industry?

Major companies operating in the medical device clinical trials market are Abbott Laboratories, Siemens Healthineers, Stryker Corporation, Philips Healthcare, Baxter International, Roche Diagnostics, ICON, Intuitive Surgical, Edwards Lifesciences, Fortrea, Medidata, NAMSA, Veranex, TFS HealthScience, Avania, Parexel, Meditrial, Syneos Health, Qserve CRO, Clinius Ltd, Eclevar Medtech, 1med Sa, ISS AG

View The Full Medical Device Clinical Trials Market Report:

https://thebusinessresearchcompany.com/report/medical-device-clinical-trials-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Medical Device Clinical Trials Market Geographic Analysis: Where Is Demand Rising Fastest?

North America was the largest region in the medical device clinical trials market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical device clinical trials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.

Medical Device Clinical Trials Market CAGR Outlook And Future Development

The medical device clinical trials market has experienced significant expansion in recent years. This market is projected to rise from $18.07 billion in 2025 to $19.36 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.2%. Historically, this growth can be ascribed to several factors, including an increase in medical device innovation, strict regulatory approval mandates, a heightened demand for patient safety validation, the enlargement of hospital-based clinical research, and greater investment in generating clinical evidence.

The medical device clinical trials market size is projected to experience substantial expansion over the upcoming years. It is forecast to reach $25.35 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 7.0%. Factors contributing to this anticipated growth during the forecast period include the rise of wearable and connected medical technologies, heightened regulatory oversight concerning device effectiveness, the proliferation of digital platforms for trials, a greater embrace of remote patient monitoring within studies, and the growing internationalization of clinical research. Key trends anticipated during the same period encompass the growing implementation of decentralized clinical trials, the expanding application of real-world evidence in device studies, an intensified emphasis on post-market approval and prolonged safety evaluations, the broadening of adaptive and hybrid trial methodologies, and a heightened need for trial management that adheres strictly to regulatory standards.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=61859328&type=smp&name=Medical%20Device%20Clinical%20Trials%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Medical Device Clinical Trials Market Demand Drivers Opening New Revenue Streams

The increasing occurrence of chronic diseases is projected to drive the growth of the medical device clinical trials market moving forward. These are long-term health conditions that advance slowly and necessitate continuous medical management. The proliferation of chronic diseases stems from sedentary lifestyles, where individuals spend extended hours seated at desks or engaged with electronic devices. This behavior reduces calorie expenditure and weakens cardiovascular health, contributing to conditions such as obesity, diabetes, and hypertension. The escalating incidence of chronic diseases, in turn, boosts the requirement for medical device clinical trials to create and validate innovative devices for effective diagnosis, treatment, and management. For instance, in June 2023, the Institute for Health Metrics and Evaluation, a US-based public health research institute, reported that over half a billion people globally were living with diabetes. This number is expected to more than double, reaching 1.3 billion people by 2050. Therefore, the rising prevalence of chronic diseases is accelerating the growth of the medical device clinical trials market.

Medical Device Clinical Trials Market Segment Landscape And Growth Outlook

The medical device clinical trials market covered in this report is segmented –

1) By Study Type: Feasibility And Pilot Study, Pivotal Study, FDA Premarket Approval (PMA) Application, Post-Approval Study

2) By Indication: Cardiovascular Devices, Neurology Devices, Orthopedic Devices, Diagnostic Imaging, Anesthesia And Respiratory Devices, Other Indications

3) By Study Design: Interventional, Observational, Expanded Access

Subsegments:

1) By Feasibility And Pilot Study: First-in-Human (FIH) Trials, Device Safety Assessment, Procedural Feasibility Studies, Prototype Testing

2) By Pivotal Study: Comparative Effectiveness Studies, Randomized Controlled Trials (RCTs), Non-Inferiority Trials, Superiority Trials

3) By FDA PMA (Pre-Market Approval) Application: Clinical Data Submission, Device Risk Analysis, Effectiveness Evidence Studies

4) By Post-Approval Study: Long-Term Safety Monitoring, Real-World Evidence Collection, Registry Studies, Comparative Outcome Studies

Medical Device Clinical Trials Market Trends Powering Strategic Industry Growth

Major companies active in the medical device clinical trials market are concentrating on developing AI-powered medical device software to streamline clinical trial protocols and resource allocation, aiming to boost trial efficiency and reduce expenditures. AI-powered medical device software refers to healthcare software that employs artificial intelligence algorithms, particularly machine learning or deep learning, to support or automate medical functions. For instance, in January 2025, Risklick, a pharmaceutical firm based in Switzerland, launched Protocol AI, an AI-driven software designed to accelerate and optimize clinical trials for medical devices. Protocol AI utilizes Natural Language Processing (NLP) and Machine Learning (ML) to analyze clinical data, publications, and regulatory documents, thereby automatically drafting clinical trial protocols within minutes. This innovation significantly decreases the time and cost associated with protocol development, which traditionally takes approximately six months, and has already shown up to a 50% reduction in document development time for medicinal products.

Medical Device Clinical Trials Market Competitive Landscape: Who Leads The Industry?

Major companies operating in the medical device clinical trials market are Abbott Laboratories, Siemens Healthineers, Stryker Corporation, Philips Healthcare, Baxter International, Roche Diagnostics, ICON, Intuitive Surgical, Edwards Lifesciences, Fortrea, Medidata, NAMSA, Veranex, TFS HealthScience, Avania, Parexel, Meditrial, Syneos Health, Qserve CRO, Clinius Ltd, Eclevar Medtech, 1med Sa, ISS AG

View The Full Medical Device Clinical Trials Market Report:

https://thebusinessresearchcompany.com/report/medical-device-clinical-trials-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Medical Device Clinical Trials Market Geographic Analysis: Where Is Demand Rising Fastest?

North America was the largest region in the medical device clinical trials market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical device clinical trials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

Medical Device Clinical Trials Market Growth Potential: How Will Market Size Change Through 2030?

The medical device clinical trials sector has experienced robust expansion over recent years. Projected figures indicate an increase from $18.07 billion in 2025 to $19.36 billion in 2026, reflecting a compound annual growth rate (CAGR) of 7.2%. This historical growth has been driven by factors such as advancements in medical device innovation, strict regulatory approval processes, a heightened need for patient safety verification, the broadening of clinical research conducted within hospital settings, and greater funding directed toward the production of clinical evidence.

The market for clinical trials involving medical devices is projected to experience substantial expansion in the coming years. By 2030, its value is anticipated to reach $25.35 billion, reflecting a compound annual growth rate (CAGR) of 7.0%. This anticipated growth during the forecast period is driven by factors such as the rise of wearable and connected medical devices, heightened regulatory demands for device performance, the broadening of digital trial platforms, greater utilization of remote patient monitoring in studies, and the increasing globalization of clinical research. Key trends shaping the forecast period involve the growing adoption of decentralized clinical trials, enhanced integration of real-world evidence in device studies, a heightened emphasis on post-approval and long-term safety evaluations, the expansion of adaptive and hybrid trial frameworks, and a rising need for regulatory-compliant trial management processes.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24295&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

#Medical Device Clinical Trials Market Growth Factors: Which Forces Are Supporting Market Expansion?

The growing incidence of chronic illnesses is anticipated to accelerate the expansion of the medical device clinical trials market in the foreseeable future. These conditions, characterized as long-term health issues that advance gradually and demand continuous medical attention, are becoming more widespread due to inactive lifestyles—where individuals spend extended periods seated at desks or using digital gadgets, resulting in reduced energy expenditure and compromised cardiovascular health, which in turn contributes to ailments like obesity, diabetes, and hypertension. This increase in chronic diseases fuels the necessity for medical device clinical trials aimed at creating and verifying novel instruments for efficient diagnosis, therapy, and oversight. For example, in June 2023, the Institute for Health Metrics and Evaluation, a public health research body based in the United States, disclosed that over half a billion people worldwide were afflicted with diabetes, a figure projected to exceed 1.3 billion by 2050. Consequently, the escalating frequency of chronic diseases is propelling the advancement of the medical device clinical trials market.

Medical Device Clinical Trials Market Segment Performance And Strategic Opportunities

The medical device clinical trials market covered in this report is segmented –

1) By Study Type: Feasibility And Pilot Study, Pivotal Study, FDA Premarket Approval (PMA) Application, Post-Approval Study

2) By Indication: Cardiovascular Devices, Neurology Devices, Orthopedic Devices, Diagnostic Imaging, Anesthesia And Respiratory Devices, Other Indications

3) By Study Design: Interventional, Observational, Expanded Access

Subsegments:

1) By Feasibility And Pilot Study: First-in-Human (FIH) Trials, Device Safety Assessment, Procedural Feasibility Studies, Prototype Testing

2) By Pivotal Study: Comparative Effectiveness Studies, Randomized Controlled Trials (RCTs), Non-Inferiority Trials, Superiority Trials

3) By FDA PMA (Pre-Market Approval) Application: Clinical Data Submission, Device Risk Analysis, Effectiveness Evidence Studies

4) By Post-Approval Study: Long-Term Safety Monitoring, Real-World Evidence Collection, Registry Studies, Comparative Outcome Studies

Medical Device Clinical Trials Market Industry Trends: What Changes Are Reshaping Demand?

Key players in the medical device clinical trials market are increasingly concentrating on the creation of AI-driven medical device software to improve the efficiency of clinical trial protocols and resource management, thereby boosting trial effectiveness and lowering expenses. Such AI-powered software is utilized in healthcare settings, employing artificial intelligence algorithms—particularly machine learning or deep learning—to assist with or automate medical functions. A notable example occurred in January 2025, when Risklick, a pharmaceutical firm based in Switzerland, introduced Protocol AI, an artificial intelligence tool aimed at speeding up and refining clinical trials for medical devices. By leveraging Natural Language Processing (NLP) and Machine Learning (ML), Protocol AI examines clinical data, scientific publications, and regulatory materials, enabling the automatic generation of clinical trial protocols within minutes. This advancement dramatically cuts down the time and financial resources needed for protocol creation, a process that typically spans around six months, and has already achieved up to a 50% decrease in document development time for medicinal products.

Medical Device Clinical Trials Market Key Players: Which Companies Shape Industry Competition?

Major companies operating in the medical device clinical trials market are Abbott Laboratories, Siemens Healthineers, Stryker Corporation, Philips Healthcare, Baxter International, Roche Diagnostics, ICON, Intuitive Surgical, Edwards Lifesciences, Fortrea, Medidata, NAMSA, Veranex, TFS HealthScience, Avania, Parexel, Meditrial, Syneos Health, Qserve CRO, Clinius Ltd, Eclevar Medtech, 1med Sa, ISS AG

Access The Complete Medical Device Clinical Trials Market Report:

https://www.thebusinessresearchcompany.com/report/medical-device-clinical-trials-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Medical Device Clinical Trials Market Leading Geography: Which Region Generates The Most Revenue?

North America was the largest region in the medical device clinical trials market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical device clinical trials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Are The Forecasted Market Size Figures For The Medical Device Clinical Trials Market In 2026 And 2030?

The medical device clinical trials market size has seen significant expansion in recent years. This market is set to increase from $18.07 billion in 2025 to $19.36 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 7.2%. Factors contributing to its historical growth include advances in medical device innovation, rigorous regulatory approval processes, a heightened need for patient safety validation, the broadening scope of hospital-based clinical research, and increased investment in the generation of clinical evidence.

The medical device clinical trials market is anticipated to show robust growth in the coming years. Its value is forecast to reach $25.35 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.0%. This projected growth is driven by several factors, including the proliferation of wearable and connected medical devices, heightened regulatory oversight concerning device performance, the broadening of digital trial platforms, a surge in remote patient monitoring utilization within trials, and the expanding globalization of clinical research. Key developments expected during this period encompass the wider embrace of decentralized clinical trials, a greater reliance on real-world evidence in device evaluations, an increased emphasis on post-market approval and prolonged safety investigations, the development of adaptive and hybrid trial methodologies, and a heightened need for trial management that adheres strictly to regulations.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24295&type=smp

What Primary Factors Are Fueling The Expansion Of The Medical Device Clinical Trials Market?

The increasing occurrence of chronic diseases is anticipated to stimulate the expansion of the medical device clinical trials market in the future. Chronic diseases are enduring health issues characterized by gradual progression and requiring continuous medical oversight. The proliferation of these conditions is attributable to increasingly inactive lifestyles, involving extended periods of sitting or device usage, which diminishes calorie burning and compromises cardiovascular well-being, contributing to conditions like obesity, diabetes, and hypertension. This rise in chronic diseases consequently necessitates medical device clinical trials to create and substantiate advanced devices for precise diagnosis, successful treatment, and overall management. Illustratively, in June 2023, the US-based public health research institute, the Institute for Health Metrics and Evaluation, disclosed that over half a billion individuals worldwide suffered from diabetes. This figure is projected to exceed twice its current size, reaching 1.3 billion people by the year 2050. Hence, the growing prevalence of chronic diseases serves as a key driver for the growth of the medical device clinical trials market.

Which Segment-Based Categories Are Covered In The Medical Device Clinical Trials Market?

The medical device clinical trials market covered in this report is segmented –

1) By Study Type: Feasibility And Pilot Study, Pivotal Study, FDA Premarket Approval (PMA) Application, Post-Approval Study

2) By Indication: Cardiovascular Devices, Neurology Devices, Orthopedic Devices, Diagnostic Imaging, Anesthesia And Respiratory Devices, Other Indications

3) By Study Design: Interventional, Observational, Expanded Access

Subsegments:

1) By Feasibility And Pilot Study: First-in-Human (FIH) Trials, Device Safety Assessment, Procedural Feasibility Studies, Prototype Testing

2) By Pivotal Study: Comparative Effectiveness Studies, Randomized Controlled Trials (RCTs), Non-Inferiority Trials, Superiority Trials

3) By FDA PMA (Pre-Market Approval) Application: Clinical Data Submission, Device Risk Analysis, Effectiveness Evidence Studies

4) By Post-Approval Study: Long-Term Safety Monitoring, Real-World Evidence Collection, Registry Studies, Comparative Outcome Studies

Which Trends Are Affecting The Medical Device Clinical Trials Market Framework?

Major companies operating in the medical device clinical trials market are focusing on the development of AI-driven medical device software to optimize clinical trial protocols and resource allocation, thereby enhancing trial efficiency and reducing costs. AI-powered medical device software describes healthcare software that leverages artificial intelligence (AI) algorithms, specifically machine learning or deep learning, to support or automate medical tasks. For instance, in January 2025, Risklick, a Switzerland-based pharmaceutical firm, launched Protocol AI, an AI-based software engineered to accelerate and optimize clinical trials for medical devices. Protocol AI utilizes Natural Language Processing (NLP) and Machine Learning (ML) to analyze clinical data, publications, and regulatory documents, facilitating the automatic drafting of clinical trial protocols within minutes. This innovation significantly cuts down the time and expense required for protocol development, a process that traditionally takes about six months, and has already demonstrated up to a 50% reduction in document development time for medicinal products.

Who Are The Leading Firms Participating In The Medical Device Clinical Trials Market?

Major companies operating in the medical device clinical trials market are Abbott Laboratories, Siemens Healthineers, Stryker Corporation, Philips Healthcare, Baxter International, Roche Diagnostics, ICON, Intuitive Surgical, Edwards Lifesciences, Fortrea, Medidata, NAMSA, Veranex, TFS HealthScience, Avania, Parexel, Meditrial, Syneos Health, Qserve CRO, Clinius Ltd, Eclevar Medtech, 1med Sa, ISS AG

Access The Complete Medical Device Clinical Trials Market Report:

https://www.thebusinessresearchcompany.com/report/medical-device-clinical-trials-global-market-report

Which Geographic Region Represents The Largest Medical Device Clinical Trials Market Share?

North America was the largest region in the medical device clinical trials market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical device clinical trials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Medical Device Clinical Trials Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=24295&type=smp

Browse Through More Reports Similar to the Global Medical Device Clinical Trials Market 2026, By The Business Research Company

Clinical Trial Supplies Market Report 2026

https://www.thebusinessresearchcompany.com/report/clinical-trial-supplies-global-market-report

Virtual Clinical Trials Market Report 2026

https://www.thebusinessresearchcompany.com/report/virtual-clinical-trials-global-market-report

Medical Device Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/medical-device-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Expansion In Market Value Is Forecasted For The Medical Device Clinical Trials Market Between 2026 And 2030?

The medical device clinical trials market size has experienced robust expansion in recent years. It is projected to increase from $18.07 billion in 2025 to $19.36 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.2%. This historical growth can be attributed to several factors, including heightened medical device innovation, rigorous regulatory approval mandates, an increasing need for patient safety validation, the broadening of hospital-based clinical research activities, and greater investment in generating clinical evidence.

The medical device clinical trials market size is projected to experience robust growth in the coming years. This market is anticipated to reach $25.35 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.0%. This projected expansion stems from factors such as the growth of wearable and connected medical devices, heightened regulatory scrutiny concerning device performance, the broadening of digital trial platforms, increased uptake of remote patient monitoring within trials, and the growing globalization of clinical studies. Key trends anticipated include a greater embrace of decentralized clinical trials, the expanding application of real-world evidence in device trials, an elevated emphasis on post-approval and long-term safety studies, the spread of adaptive and hybrid trial designs, and an escalating need for regulatory-compliant trial management.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24295&type=smp

What Key Factors Are Affecting The Medical Device Clinical Trials Market Demand?

The increasing prevalence of chronic diseases is projected to drive the expansion of the medical device clinical trials market moving forward. Chronic diseases are long-term health issues that advance gradually and necessitate ongoing medical care. The rise in these conditions is attributed to sedentary lifestyles, where individuals spend extended periods seated or using electronic devices, leading to reduced calorie expenditure and compromised cardiovascular health, which contributes to issues such as obesity, diabetes, and hypertension. This growth in chronic diseases generates a need for medical device clinical trials to develop and validate novel devices for effective diagnosis, treatment, and management. As an illustration, in June 2023, the Institute for Health Metrics and Evaluation, a US-based public health research institute, reported that over half a billion people globally were living with diabetes, a number projected to more than double to 1.3 billion people by 2050. Thus, the escalating incidence of chronic diseases is fueling the growth of the medical device clinical trials market.

How Are Different Segments Classified In The Medical Device Clinical Trials Market Segment Analysis?

The medical device clinical trials market covered in this report is segmented –

1) By Study Type: Feasibility And Pilot Study, Pivotal Study, FDA Premarket Approval (PMA) Application, Post-Approval Study

2) By Indication: Cardiovascular Devices, Neurology Devices, Orthopedic Devices, Diagnostic Imaging, Anesthesia And Respiratory Devices, Other Indications

3) By Study Design: Interventional, Observational, Expanded Access

Subsegments:

1) By Feasibility And Pilot Study: First-in-Human (FIH) Trials, Device Safety Assessment, Procedural Feasibility Studies, Prototype Testing

2) By Pivotal Study: Comparative Effectiveness Studies, Randomized Controlled Trials (RCTs), Non-Inferiority Trials, Superiority Trials

3) By FDA PMA (Pre-Market Approval) Application: Clinical Data Submission, Device Risk Analysis, Effectiveness Evidence Studies

4) By Post-Approval Study: Long-Term Safety Monitoring, Real-World Evidence Collection, Registry Studies, Comparative Outcome Studies

What Trends Are Influencing The Medical Device Clinical Trials Market?

Major companies operating in the medical device clinical trials market are increasingly focusing on developing AI-powered medical device software. This strategy aims to optimize clinical trial protocols and resource allocation, thereby enhancing trial efficiency and reducing overall costs. AI-powered medical device software refers to applications within healthcare that employ artificial intelligence (AI) algorithms, especially machine learning or deep learning, to either support or automate medical tasks. For instance, in January 2025, Risklick, a Switzerland-based pharmaceutical company, launched Protocol AI. This AI-based software is specifically designed to accelerate and optimize clinical trials for medical devices. Protocol AI leverages Natural Language Processing (NLP) and Machine Learning (ML) to analyze clinical data, publications, and regulatory documents, enabling it to automatically draft clinical trial protocols in minutes. This innovation significantly reduces the time and cost typically required for protocol development, a process that conventionally takes about six months, and has already demonstrated up to a 50% reduction in document development time for medicinal products.

Who Are The Companies Driving Activity In The Medical Device Clinical Trials Market?

Major companies operating in the medical device clinical trials market are Abbott Laboratories, Siemens Healthineers, Stryker Corporation, Philips Healthcare, Baxter International, Roche Diagnostics, ICON, Intuitive Surgical, Edwards Lifesciences, Fortrea, Medidata, NAMSA, Veranex, TFS HealthScience, Avania, Parexel, Meditrial, Syneos Health, Qserve CRO, Clinius Ltd, Eclevar Medtech, 1med Sa, ISS AG

Get The Full Medical Device Clinical Trials Market Report:

https://www.thebusinessresearchcompany.com/report/medical-device-clinical-trials-global-market-report

Which Region Represents The Largest Share Of The Medical Device Clinical Trials Market?

North America was the largest region in the medical device clinical trials market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical device clinical trials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Medical Device Clinical Trials Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/medical-device-clinical-trials-global-market-report

Browse Through More Reports Similar to the Global Medical Device Clinical Trials Market 2026, By The Business Research Company

Clinical Trial Supplies Market Report 2026

https://www.thebusinessresearchcompany.com/report/clinical-trial-supplies-global-market-report

Virtual Clinical Trials Market Report 2026

https://www.thebusinessresearchcompany.com/report/virtual-clinical-trials-global-market-report

Medical Device Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/medical-device-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Forecasted Market Value Of The Medical Device Clinical Trials Market Across 2026–2030?

The market size for medical device clinical trials has shown strong growth in recent years. It is forecast to increase from $18.07 billion in 2025 to $19.36 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.2%. The expansion observed in the historical period can be attributed to advancements in medical device innovation, strict regulatory approval criteria, a growing need for patient safety validation, the widening scope of hospital-based clinical research, and increased investment in generating clinical evidence.

The medical device clinical trials market is projected to experience substantial expansion over the next few years. This sector is anticipated to reach $25.35 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.0%. This expected growth during the forecast period is primarily driven by factors such as the increasing development of wearable and connected medical devices, heightened regulatory oversight concerning device performance, the broadening of digital trial platforms, greater integration of remote patient monitoring in trials, and the ongoing globalization of clinical studies. Furthermore, prominent trends anticipated during this period include the wider adoption of decentralized clinical trials, a growing reliance on real-world evidence in device evaluations, an increased focus on post-approval and long-term safety investigations, the expansion of adaptive and hybrid trial methodologies, and a rising imperative for regulatory-compliant trial management.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24295&type=smp

What Primary Drivers Are Shaping The Development Of The Medical Device Clinical Trials Market?

The increasing occurrence of chronic diseases is anticipated to fuel the expansion of the medical device clinical trials market in the future. These conditions are defined as long-term health issues that evolve gradually and necessitate continuous medical attention. The surge in chronic diseases is attributed to sedentary lifestyles, where individuals spend extended periods seated at desks or engaging with electronic devices, leading to decreased calorie burning and compromised cardiovascular health, consequently fostering conditions like obesity, diabetes, and hypertension. This escalation in chronic illnesses necessitates medical device clinical trials to create and authenticate innovative devices for accurate diagnosis, effective treatment, and comprehensive management. As an illustration, in June 2023, the Institute for Health Metrics and Evaluation, a US-based public health research institute, disclosed that more than half a billion individuals worldwide were afflicted with diabetes. This figure is projected to more than double, reaching 1.3 billion people by 2050. Consequently, the growing prevalence of chronic diseases is a key factor propelling the development of the medical device clinical trials market.

What Segmentation Levels Are Considered In The Medical Device Clinical Trials Market?

The medical device clinical trials market covered in this report is segmented –

1) By Study Type: Feasibility And Pilot Study, Pivotal Study, FDA Premarket Approval (PMA) Application, Post-Approval Study

2) By Indication: Cardiovascular Devices, Neurology Devices, Orthopedic Devices, Diagnostic Imaging, Anesthesia And Respiratory Devices, Other Indications

3) By Study Design: Interventional, Observational, Expanded Access

Subsegments:

1) By Feasibility And Pilot Study: First-in-Human (FIH) Trials, Device Safety Assessment, Procedural Feasibility Studies, Prototype Testing

2) By Pivotal Study: Comparative Effectiveness Studies, Randomized Controlled Trials (RCTs), Non-Inferiority Trials, Superiority Trials

3) By FDA PMA (Pre-Market Approval) Application: Clinical Data Submission, Device Risk Analysis, Effectiveness Evidence Studies

4) By Post-Approval Study: Long-Term Safety Monitoring, Real-World Evidence Collection, Registry Studies, Comparative Outcome Studies

What Trends Are Projected To Affect The Medical Device Clinical Trials Market?

Leading businesses within the medical device clinical trials sector are concentrating on creating AI-enabled medical device software, aiming to streamline clinical trial protocols and resource deployment to boost trial effectiveness and lower expenses. This AI-driven medical device software encompasses applications in healthcare that utilize artificial intelligence (AI) algorithms, particularly machine learning or deep learning, either to assist with or to automate various medical responsibilities. As an illustration, in January 2025, Risklick, a pharmaceutical firm located in Switzerland, introduced Protocol AI, an AI-driven software solution intended to expedite and refine clinical trials specifically for medical devices. Protocol AI employs Natural Language Processing (NLP) and Machine Learning (ML) capabilities to examine clinical data, published works, and regulatory paperwork, generating drafts of clinical trial protocols automatically within minutes. This groundbreaking tool substantially cuts down the time and expenditures associated with protocol creation, a process that typically spans approximately six months, and it has already achieved up to a 50% decrease in document development duration for medicinal products.

Which Leading Firms Are Contributing To The Growth Of The Medical Device Clinical Trials Market?

Major companies operating in the medical device clinical trials market are Abbott Laboratories, Siemens Healthineers, Stryker Corporation, Philips Healthcare, Baxter International, Roche Diagnostics, ICON, Intuitive Surgical, Edwards Lifesciences, Fortrea, Medidata, NAMSA, Veranex, TFS HealthScience, Avania, Parexel, Meditrial, Syneos Health, Qserve CRO, Clinius Ltd, Eclevar Medtech, 1med Sa, ISS AG

Read the full medical device clinical trials market report here:

https://www.thebusinessresearchcompany.com/report/medical-device-clinical-trials-global-market-report

How Does The Medical Device Clinical Trials Market Perform Across Major Global Regions?

North America was the largest region in the medical device clinical trials market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical device clinical trials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Medical Device Clinical Trials Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24295&type=smp

Browse Through More Reports Similar to the Global Medical Device Clinical Trials Market 2026, By The Business Research Company

Clinical Trial Supplies Market Report 2026

https://www.thebusinessresearchcompany.com/report/clinical-trial-supplies-global-market-report

Virtual Clinical Trials Market Report 2026

https://www.thebusinessresearchcompany.com/report/virtual-clinical-trials-global-market-report

Medical Device Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/medical-device-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Forecasted Market Value Of The Medical Device Clinical Trials Market Across 2026–2030?

The market size for medical device clinical trials has shown strong growth in recent years. It is forecast to increase from $18.07 billion in 2025 to $19.36 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.2%. The expansion observed in the historical period can be attributed to advancements in medical device innovation, strict regulatory approval criteria, a growing need for patient safety validation, the widening scope of hospital-based clinical research, and increased investment in generating clinical evidence.

The medical device clinical trials market is projected to experience substantial expansion over the next few years. This sector is anticipated to reach $25.35 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.0%. This expected growth during the forecast period is primarily driven by factors such as the increasing development of wearable and connected medical devices, heightened regulatory oversight concerning device performance, the broadening of digital trial platforms, greater integration of remote patient monitoring in trials, and the ongoing globalization of clinical studies. Furthermore, prominent trends anticipated during this period include the wider adoption of decentralized clinical trials, a growing reliance on real-world evidence in device evaluations, an increased focus on post-approval and long-term safety investigations, the expansion of adaptive and hybrid trial methodologies, and a rising imperative for regulatory-compliant trial management.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24295&type=smp

What Primary Drivers Are Shaping The Development Of The Medical Device Clinical Trials Market?

The increasing occurrence of chronic diseases is anticipated to fuel the expansion of the medical device clinical trials market in the future. These conditions are defined as long-term health issues that evolve gradually and necessitate continuous medical attention. The surge in chronic diseases is attributed to sedentary lifestyles, where individuals spend extended periods seated at desks or engaging with electronic devices, leading to decreased calorie burning and compromised cardiovascular health, consequently fostering conditions like obesity, diabetes, and hypertension. This escalation in chronic illnesses necessitates medical device clinical trials to create and authenticate innovative devices for accurate diagnosis, effective treatment, and comprehensive management. As an illustration, in June 2023, the Institute for Health Metrics and Evaluation, a US-based public health research institute, disclosed that more than half a billion individuals worldwide were afflicted with diabetes. This figure is projected to more than double, reaching 1.3 billion people by 2050. Consequently, the growing prevalence of chronic diseases is a key factor propelling the development of the medical device clinical trials market.

What Segmentation Levels Are Considered In The Medical Device Clinical Trials Market?

The medical device clinical trials market covered in this report is segmented –

1) By Study Type: Feasibility And Pilot Study, Pivotal Study, FDA Premarket Approval (PMA) Application, Post-Approval Study

2) By Indication: Cardiovascular Devices, Neurology Devices, Orthopedic Devices, Diagnostic Imaging, Anesthesia And Respiratory Devices, Other Indications

3) By Study Design: Interventional, Observational, Expanded Access

Subsegments:

1) By Feasibility And Pilot Study: First-in-Human (FIH) Trials, Device Safety Assessment, Procedural Feasibility Studies, Prototype Testing

2) By Pivotal Study: Comparative Effectiveness Studies, Randomized Controlled Trials (RCTs), Non-Inferiority Trials, Superiority Trials

3) By FDA PMA (Pre-Market Approval) Application: Clinical Data Submission, Device Risk Analysis, Effectiveness Evidence Studies

4) By Post-Approval Study: Long-Term Safety Monitoring, Real-World Evidence Collection, Registry Studies, Comparative Outcome Studies

What Trends Are Projected To Affect The Medical Device Clinical Trials Market?

Leading businesses within the medical device clinical trials sector are concentrating on creating AI-enabled medical device software, aiming to streamline clinical trial protocols and resource deployment to boost trial effectiveness and lower expenses. This AI-driven medical device software encompasses applications in healthcare that utilize artificial intelligence (AI) algorithms, particularly machine learning or deep learning, either to assist with or to automate various medical responsibilities. As an illustration, in January 2025, Risklick, a pharmaceutical firm located in Switzerland, introduced Protocol AI, an AI-driven software solution intended to expedite and refine clinical trials specifically for medical devices. Protocol AI employs Natural Language Processing (NLP) and Machine Learning (ML) capabilities to examine clinical data, published works, and regulatory paperwork, generating drafts of clinical trial protocols automatically within minutes. This groundbreaking tool substantially cuts down the time and expenditures associated with protocol creation, a process that typically spans approximately six months, and it has already achieved up to a 50% decrease in document development duration for medicinal products.

Which Leading Firms Are Contributing To The Growth Of The Medical Device Clinical Trials Market?

Major companies operating in the medical device clinical trials market are Abbott Laboratories, Siemens Healthineers, Stryker Corporation, Philips Healthcare, Baxter International, Roche Diagnostics, ICON, Intuitive Surgical, Edwards Lifesciences, Fortrea, Medidata, NAMSA, Veranex, TFS HealthScience, Avania, Parexel, Meditrial, Syneos Health, Qserve CRO, Clinius Ltd, Eclevar Medtech, 1med Sa, ISS AG

Read the full medical device clinical trials market report here:

https://www.thebusinessresearchcompany.com/report/medical-device-clinical-trials-global-market-report

How Does The Medical Device Clinical Trials Market Perform Across Major Global Regions?

North America was the largest region in the medical device clinical trials market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical device clinical trials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Medical Device Clinical Trials Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24295&type=smp

Browse Through More Reports Similar to the Global Medical Device Clinical Trials Market 2026, By The Business Research Company

Clinical Trial Supplies Market Report 2026

https://www.thebusinessresearchcompany.com/report/clinical-trial-supplies-global-market-report

Virtual Clinical Trials Market Report 2026

https://www.thebusinessresearchcompany.com/report/virtual-clinical-trials-global-market-report

Medical Device Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/medical-device-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Forecasted Market Value Of The Medical Device Clinical Trials Market Across 2026–2030?

The market size for medical device clinical trials has shown strong growth in recent years. It is forecast to increase from $18.07 billion in 2025 to $19.36 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.2%. The expansion observed in the historical period can be attributed to advancements in medical device innovation, strict regulatory approval criteria, a growing need for patient safety validation, the widening scope of hospital-based clinical research, and increased investment in generating clinical evidence.

The medical device clinical trials market is projected to experience substantial expansion over the next few years. This sector is anticipated to reach $25.35 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.0%. This expected growth during the forecast period is primarily driven by factors such as the increasing development of wearable and connected medical devices, heightened regulatory oversight concerning device performance, the broadening of digital trial platforms, greater integration of remote patient monitoring in trials, and the ongoing globalization of clinical studies. Furthermore, prominent trends anticipated during this period include the wider adoption of decentralized clinical trials, a growing reliance on real-world evidence in device evaluations, an increased focus on post-approval and long-term safety investigations, the expansion of adaptive and hybrid trial methodologies, and a rising imperative for regulatory-compliant trial management.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24295&type=smp

What Primary Drivers Are Shaping The Development Of The Medical Device Clinical Trials Market?

The increasing occurrence of chronic diseases is anticipated to fuel the expansion of the medical device clinical trials market in the future. These conditions are defined as long-term health issues that evolve gradually and necessitate continuous medical attention. The surge in chronic diseases is attributed to sedentary lifestyles, where individuals spend extended periods seated at desks or engaging with electronic devices, leading to decreased calorie burning and compromised cardiovascular health, consequently fostering conditions like obesity, diabetes, and hypertension. This escalation in chronic illnesses necessitates medical device clinical trials to create and authenticate innovative devices for accurate diagnosis, effective treatment, and comprehensive management. As an illustration, in June 2023, the Institute for Health Metrics and Evaluation, a US-based public health research institute, disclosed that more than half a billion individuals worldwide were afflicted with diabetes. This figure is projected to more than double, reaching 1.3 billion people by 2050. Consequently, the growing prevalence of chronic diseases is a key factor propelling the development of the medical device clinical trials market.

What Segmentation Levels Are Considered In The Medical Device Clinical Trials Market?

The medical device clinical trials market covered in this report is segmented –

1) By Study Type: Feasibility And Pilot Study, Pivotal Study, FDA Premarket Approval (PMA) Application, Post-Approval Study

2) By Indication: Cardiovascular Devices, Neurology Devices, Orthopedic Devices, Diagnostic Imaging, Anesthesia And Respiratory Devices, Other Indications

3) By Study Design: Interventional, Observational, Expanded Access

Subsegments:

1) By Feasibility And Pilot Study: First-in-Human (FIH) Trials, Device Safety Assessment, Procedural Feasibility Studies, Prototype Testing

2) By Pivotal Study: Comparative Effectiveness Studies, Randomized Controlled Trials (RCTs), Non-Inferiority Trials, Superiority Trials

3) By FDA PMA (Pre-Market Approval) Application: Clinical Data Submission, Device Risk Analysis, Effectiveness Evidence Studies

4) By Post-Approval Study: Long-Term Safety Monitoring, Real-World Evidence Collection, Registry Studies, Comparative Outcome Studies

What Trends Are Projected To Affect The Medical Device Clinical Trials Market?

Leading businesses within the medical device clinical trials sector are concentrating on creating AI-enabled medical device software, aiming to streamline clinical trial protocols and resource deployment to boost trial effectiveness and lower expenses. This AI-driven medical device software encompasses applications in healthcare that utilize artificial intelligence (AI) algorithms, particularly machine learning or deep learning, either to assist with or to automate various medical responsibilities. As an illustration, in January 2025, Risklick, a pharmaceutical firm located in Switzerland, introduced Protocol AI, an AI-driven software solution intended to expedite and refine clinical trials specifically for medical devices. Protocol AI employs Natural Language Processing (NLP) and Machine Learning (ML) capabilities to examine clinical data, published works, and regulatory paperwork, generating drafts of clinical trial protocols automatically within minutes. This groundbreaking tool substantially cuts down the time and expenditures associated with protocol creation, a process that typically spans approximately six months, and it has already achieved up to a 50% decrease in document development duration for medicinal products.

Which Leading Firms Are Contributing To The Growth Of The Medical Device Clinical Trials Market?

Major companies operating in the medical device clinical trials market are Abbott Laboratories, Siemens Healthineers, Stryker Corporation, Philips Healthcare, Baxter International, Roche Diagnostics, ICON, Intuitive Surgical, Edwards Lifesciences, Fortrea, Medidata, NAMSA, Veranex, TFS HealthScience, Avania, Parexel, Meditrial, Syneos Health, Qserve CRO, Clinius Ltd, Eclevar Medtech, 1med Sa, ISS AG

Read the full medical device clinical trials market report here:

https://www.thebusinessresearchcompany.com/report/medical-device-clinical-trials-global-market-report

How Does The Medical Device Clinical Trials Market Perform Across Major Global Regions?

North America was the largest region in the medical device clinical trials market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical device clinical trials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Medical Device Clinical Trials Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24295&type=smp

Browse Through More Reports Similar to the Global Medical Device Clinical Trials Market 2026, By The Business Research Company

Clinical Trial Supplies Market Report 2026

https://www.thebusinessresearchcompany.com/report/clinical-trial-supplies-global-market-report

Virtual Clinical Trials Market Report 2026

https://www.thebusinessresearchcompany.com/report/virtual-clinical-trials-global-market-report

Medical Device Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/medical-device-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the medical device clinical trials market from 2026–2035 with trusted insights from The Business Research Company

What size range is anticipated for the Medical Device Clinical Trials Market from 2026 to 2030?

The medical device clinical trials market size has experienced significant expansion in recent years. It is anticipated to grow from $18.07 billion in 2025 to $19.36 billion in 2026, at a compound annual growth rate (CAGR) of 7.2%. This market’s past growth can be attributed to increased medical device innovation, rigorous regulatory approval requirements, a heightened demand for patient safety validation, the broadening of hospital-based clinical research, and a rise in investment toward generating clinical evidence.

The medical device clinical trials market is projected to experience robust expansion over the coming years. Its valuation is anticipated to reach $25.35 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.0%. This expansion during the forecast timeframe is attributable to several factors, including the proliferation of wearable and connected medical devices, heightened regulatory oversight concerning device performance, the enlargement of digital trial platforms, the growing integration of remote patient monitoring into trials, and the increasing worldwide scope of clinical investigations. Key developments anticipated during this period encompass the greater embrace of decentralized clinical trials, the expanding utilization of real-world evidence in device studies, a heightened emphasis on post-approval and extended safety research, the broadening of adaptive and hybrid trial methodologies, and a surging requirement for trial management that adheres to regulatory standards.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24295&type=smp

What Drivers Are Affecting Demand In The Medical Device Clinical Trials Market?

The increasing occurrence of chronic diseases is anticipated to drive expansion within the medical device clinical trials market in the future. These are enduring health conditions characterized by gradual progression and a continuous need for medical care. The rise in chronic diseases stems from inactive lifestyles, where extended periods of sitting at desks or using electronic devices decrease calorie burning and impair cardiovascular health, resulting in conditions like obesity, diabetes, and hypertension. This escalation in chronic diseases necessitates medical device clinical trials to create and confirm the efficacy of novel devices for accurate diagnosis, treatment, and ongoing management. As an illustration, in June 2023, the Institute for Health Metrics and Evaluation, a US-based public health research institute, disclosed that more than half a billion people globally were affected by diabetes. This figure is projected to more than double, reaching 1.3 billion people by 2050. Consequently, the growing prevalence of chronic diseases is propelling the expansion of the medical device clinical trials market.

Which Segments Are Gaining Traction In The Medical Device Clinical Trials Market?

The medical device clinical trials market covered in this report is segmented –

1) By Study Type: Feasibility And Pilot Study, Pivotal Study, FDA Premarket Approval (PMA) Application, Post-Approval Study

2) By Indication: Cardiovascular Devices, Neurology Devices, Orthopedic Devices, Diagnostic Imaging, Anesthesia And Respiratory Devices, Other Indications

3) By Study Design: Interventional, Observational, Expanded Access

Subsegments:

1) By Feasibility And Pilot Study: First-in-Human (FIH) Trials, Device Safety Assessment, Procedural Feasibility Studies, Prototype Testing

2) By Pivotal Study: Comparative Effectiveness Studies, Randomized Controlled Trials (RCTs), Non-Inferiority Trials, Superiority Trials

3) By FDA PMA (Pre-Market Approval) Application: Clinical Data Submission, Device Risk Analysis, Effectiveness Evidence Studies

4) By Post-Approval Study: Long-Term Safety Monitoring, Real-World Evidence Collection, Registry Studies, Comparative Outcome Studies

What Industry Trends Are Transforming The Medical Device Clinical Trials Market?

Leading companies active in the medical device clinical trials market are directing their efforts toward developing AI-powered medical device software. Their goal is to refine clinical trial protocols and improve resource allocation, thereby enhancing trial efficiency and reducing overall costs. AI-powered medical device software refers to applications in healthcare that leverage artificial intelligence (AI) algorithms, specifically machine learning or deep learning, to support or automate various medical tasks. For example, in January 2025, Risklick, a pharmaceutical company based in Switzerland, unveiled Protocol AI. This AI-based software is specifically designed to accelerate and optimize clinical trials for medical devices. Protocol AI utilizes Natural Language Processing (NLP) and Machine Learning (ML) to analyze clinical data, publications, and regulatory documents, automatically generating clinical trial protocols in just minutes. This innovation significantly cuts down the time and expense typically associated with protocol development, a process that traditionally takes around six months, and has already demonstrated up to a 50% reduction in document development time for medicinal products.

Who Are The Primary Competitors In The Global Medical Device Clinical Trials Market?

Major companies operating in the medical device clinical trials market are Abbott Laboratories, Siemens Healthineers, Stryker Corporation, Philips Healthcare, Baxter International, Roche Diagnostics, ICON, Intuitive Surgical, Edwards Lifesciences, Fortrea, Medidata, NAMSA, Veranex, TFS HealthScience, Avania, Parexel, Meditrial, Syneos Health, Qserve CRO, Clinius Ltd, Eclevar Medtech, 1med Sa, ISS AG

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/medical-device-clinical-trials-global-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Medical Device Clinical Trials Market?

North America was the largest region in the medical device clinical trials market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical device clinical trials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Medical Device Clinical Trials Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24295&type=smp

Browse Through More Reports Similar to the Global Medical Device Clinical Trials Market 2026, By The Business Research Company

Clinical Trial Supplies Market Report 2026

https://www.thebusinessresearchcompany.com/report/clinical-trial-supplies-global-market-report

Virtual Clinical Trials Market Report 2026

https://www.thebusinessresearchcompany.com/report/virtual-clinical-trials-global-market-report

Medical Device Testing Market Report 2026

https://www.thebusinessresearchcompany.com/report/medical-device-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model